TORNTPHARM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Torrent Pharmaceuticals Ltd reported sales of ₹4,979 Cr, operating profit of ₹1,666 Cr (OPM 33%) and net profit of ₹534 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
TORNTPHARM quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
2,809
2,959
3,178
3,302
3,303
4,197
4,921
4,979
Expenses
1,895
1,995
2,146
2,219
2,215
2,841
3,257
3,313
Operating Profit
914
964
1,032
1,083
1,088
1,356
1,664
1,666
OPM
33%
33%
32%
33%
33%
32%
34%
33%
Other Income
33
-42
-37
-40
-23
-83
-33
-20
Interest
57
56
56
48
45
236
305
300
Depreciation
199
201
201
204
206
508
593
609
Profit before tax
691
665
738
791
814
529
733
737
Tax
27%
25%
26%
25%
22%
31%
23%
28%
Net Profit
503
498
548
591
635
364
566
534
EPS in Rs
14.86
14.71
16.19
17.46
18.76
10.76
16.72
14.04
TORNTPHARM profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
8,508
9,620
10,728
11,516
13,980
17,400
Expenses
6,077
6,778
7,360
7,795
9,421
11,626
Operating Profit
2,431
2,842
3,368
3,721
4,558
5,774
OPM
29%
30%
31%
32%
33%
33%
Other Income
-288
45
146
-1
-182
-159
Interest
255
333
354
252
385
886
Depreciation
662
707
808
795
1,119
1,916
Profit before tax
1,226
1,847
2,352
2,673
2,872
2,813
Tax
37%
33%
30%
28%
26%
-
Net Profit
777
1,245
1,656
1,911
2,138
2,099
EPS in Rs
22.97
36.79
48.94
56.47
63.92
60.28
Dividend Payout
105%
60%
57%
57%
59%
-
TORNTPHARM balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
169
169
169
169
190
Reserves
6,687
7,421
8,280
8,219
18,183
Borrowings
4,022
3,202
2,822
15,026
14,107
Other Liabilities
3,627
3,603
4,244
20,200
12,135
Total Liabilities
14,505
14,396
15,515
43,614
44,615
Fixed Assets
8,138
7,947
7,841
33,191
32,621
CWIP
361
478
488
641
404
Investments
173
156
133
948
2,160
Other Assets
5,834
5,815
7,053
8,833
9,430
Total Assets
14,505
14,396
15,515
43,614
44,615
TORNTPHARM cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
1,803
2,368
3,266
2,585
3,023
Cash from Investing Activity
-196
-2,335
-160
-549
-12,630
Cash from Financing Activity
-1,781
77
-2,780
-2,298
10,151
Net Cash Flow
-174
110
327
-262
544
Free Cash Flow
1,607
1,953
2,967
1,991
2,386
CFO/OP
91%
97%
112%
86%
84%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit